International
The Morning Science

What science found today

‹
 

Research

An experimental treatment improves the cognitive ability and gut microbiota of mice with fragile X syndrome

Medical Xpress ·

An experimental treatment improves the cognitive ability and gut microbiota of mice with fragile X syndrome

The Brief

  • Ongoing treatment with a drug that inhibits the endocannabinoid system peripherally improved memory deficits in fragile X syndrome mouse models.
  • The treatment also reduced synaptic alterations, mitigated gut microbiota dysbiosis and restored intestinal barrier integrity markers.
  • The treatment is experimental and the findings come from mice.

Why it matters

The results point to the peripheral endocannabinoid system and the gut as possible targets in fragile X syndrome research, though the evidence so far comes only from mouse models.

Who’s affected

  • researchers studying fragile X syndrome
  • neuroscientists and gut microbiome researchers

Ongoing treatment with a drug that inhibits the endocannabinoid system peripherally improves memory deficits, reduces synaptic alterations, mitigates gut microbiota dysbiosis and restores intestinal barrier integrity markers in fragile X syndrome mouse models. This experimental…

How do you feel about this?

0 Comments